Faculty members of the Targeted Drug Delivery research core are developing novel, nanoparticle-based systems for tissue-selective delivery of cancer chemotherapeutic agents, cystic fibrosis treatments, ocular disorders, and other conditions. These nanoparticle-based delivery systems are designed to silence key, cancer-driving genes in the tumors, "light up" cancer cells for easier surgical removal, kill cancer with heat, deliver mRNA-based gene therapies, or synergize wtih radiation therapy, among other useful properties.

Research Team